Robert W. Schrier, MD, Chair of Medicine

---

Dr. Robert W. Schrier led the Department of Medicine for 26 years, expanding faculty from 75 to 500 and research funding from $3M to nearly $100M. A pioneering nephrologist, he was internationally recognized for his work in kidney disease and held 45 years of continuous NIH funding. He was the only person to lead ASN, ISN, and NKF and established the department’s first endowed chair, marking a new era of philanthropic support. His greatest legacy is as a mentor, shaping generations of physician-leaders. The endowed chair in his name continues to support future physician-scientists.

Chairholder: Vineet Chopra, MD, MSc

---

As Chair of the Department of Medicine at the University of Colorado School of Medicine, Dr. Chopra oversees the education, research and clinical initiatives that will shape the physician-scientists of tomorrow. In addition to his significant leadership responsibilities, Dr. Chopra’s career focuses on translational research in hospital medicine. His aspirational goal is that no patient, at any time during their life, will experience harm from the IV device that they receive during a hospital stay. The Robert W. Schrier Endowed Chair ensures Dr. Chopra is able to dedicate critical time to moving forward key projects that study the prevention of hospital-acquired conditions.  

Learn more about Dr. Chopra here

How are the funds being used:

---

With support from the Robert W. Schrier Endowed Chair, Dr. Chopra built a research team focused on improving IV device use through patient experience data. Their work has shaped policies at every level, led to published guidelines, smartphone apps, and global education efforts. Recently, the team expanded into studying central venous catheters in cancer patients, resulting in the first-ever international guidelines for this vulnerable group.

The Henry N. Claman Endowed Chair in Medicine

---

This endowed chair honors Dr. Henry N. Claman, a pioneering immunologist whose discovery of T-B cell collaboration shaped modern immunology. A Distinguished Professor and beloved educator, he also championed the integration of arts in medicine. This chair supports future physician-scientists committed to both scientific excellence and humanism in healthcare.

Chairholder: Stephen Dreskin, MD, PhD

---

Dr. Dreskin, Professor in the Division of Allergy and Clinical Immunology and Director of the CU Allergy and Immunology Practice, leads research on peanut allergens—specifically the potent proteins Ara h 2 and Ara h 6. His lab has shown these two allergens account for about 90% of peanut allergenic activity in severely allergic patients. Using both in vitro and mouse models, his team is uncovering how these proteins trigger allergic responses. The lab also studies the molecular basis of chronic urticaria.

Learn more about Dr. Dreskin here

Previous Chair Holder: Andrew P. Fontenot, MD

Kenneth B. Poirier Cardiac Transplant Endowed Chair

---

The Kenneth B. Poirier Cardiac Transplant Endowed Chair at the University of Colorado honors Kenneth B. Poirier, Jr., whose life was extended by a heart transplant at age 56. A dedicated broadcaster and community member, Ken’s journey inspired a commitment to advancing cardiac transplant care. Made possible through the generosity of Mr. and Mrs. Millman, this endowed chair supports education and clinical care in cardiology, enabling CU to bring thought leaders in advanced heart failure and transplant to campus. These efforts enhance the student experience and foster knowledge sharing, ensuring continued innovation in heart transplantation.

Chairholder: Larry Allen, MD, MHS

---

Dr. Allen is the Head of the Division of Cardiology and an endowed chair at the University of Colorado.He specializes in advance heart failure, cardiac transplantation, and mechanical circulatory support, with a focus on improving patient outcomes and decision-making. A physician-scientist, Dr. Allen leads transformative research like the DECIDE-LVAD and EPIC-HF trials. A Colorado native, he combines his professional dedication with a love for trail running, skiing, and community involvement.

William R. Hiatt Endowed Chair in Cardiovascular Research Fund

---

This chair honors William R. Hiatt, a longtime cardiologist at CU Anschutz and holder of the Novartis Foundation Endowed Chair in Cardiovascular Research. Dr. Hiatt dedicated his career to treating patients with vascular diseases, particularly peripheral artery disease, and was involved in the EUCLID and VOYAGER clinical trials.

Chairholder: Marc Bonaca, MD, MPH, FACC, FAHA

---

Marc P. Bonaca, MD, MPH, is a Cardiologist and Vascular Medicine Specialist, Executive Director of CPC Clinical Research and CPC Community Health, and Professor of Medicine at the University of Colorado School of Medicine. He holds the William R. Hiatt Endowed Chair in Cardiovascular Research. Dr. Bonaca’s research focuses on peripheral artery disease, polyvascular disease, diabetes, and the complications of novel oncologic therapies, including cardiac, vascular, and thrombotic risks.

S. Gilbert Blount Endowed Chair in Cardiovascular Research

---

This chair was established through gifts from friends and admirers of S. Gilbert Blount, MD, including Donald G. White and family, and the CU Department of Medicine. Dr. Blount, the first division head of cardiology, served in that role for many years. This chair honors his legacy and advances research in the Division of Cardiology, improving patient care.

Chairholder: Peter Buttrick, MD

---

Peter Buttrick joined the University of Colorado School of Medicine in 2006. He has authored over 140 peer-reviewed manuscripts and serves on multiple academic journal editorial boards. Dr. Buttrick was also president of the Association of University Cardiologists and was inducted into the American Association of Physicians in 2009.

He earned his medical degree from SUNY Stony Brook, completed his residency at Michael Reese Hospital, and was a cardiology fellow at Montefiore Medical Center. His research focuses on cardiomyocyte biology and cellular adaptations in heart performance.

“Our understanding of cellular biochemistry and physiology has led to the discovery of new druggable targets, including sarcomere elements, expanding our therapeutic options.

Learn more about Dr. Buttrick here

How the funds are being used:

---

Funds support educational activities within the division, including an annual lectureship, fellow training, and recognition of outstanding scholarship, as well as post-doctoral support, in line with donor intent.

Joseph and Rose LaConte Cardiology Chair

---

Successful Denver area entrepreneurs with no known connection to the University of Colorado, Joseph and Rose LaConte made a transformative gift through their estate to support cardiology. This endowed chair is making a measurable impact at CU Anschutz by supporting research and innovation in cardiology treatments.

The LaContes, hard-working vegetable farmers, developed commercial real estate in Westminster for years as well as a drive-in movie theater; the LaConte Shopping Center in Westminster bears their name. Joseph died in 2001 at age 91; Rose died in 2006 at 94. 

Chairholder: Timothy A. McKinsey, MD

---

Dr. McKinsey is a Professor of Medicine at CU Anschutz, where he holds the Joseph and Rose LaConte Endowed Chair in Cardiology. He serves as Associate Division Head for Translational Research and founded the Consortium for Fibrosis Research & Translation (CFReT). After earning his PhD from Vanderbilt and completing postdoctoral work at UT Southwestern, he spent eight years in industry leading drug discovery teams. His lab now focuses on signaling and epigenetic mechanisms in heart failure. Twitter: @McKinseyLab

How the funds are being used:

---

Cardiovascular disease is the #1 killer in the world. Among other things, funds from the Joseph and Rose LaConte Cardiology Chair are helping to support research aimed at developing new therapies to treat cardiovascular disease.  Additionally, these funds are being used to train the next generation of leaders in the field.

Interventional Cardiology Endowed Chair

---

Interventional cardiology uses minimally invasive, catheter-based techniques—like coronary angioplasty and valve replacement—guided by advanced imaging, offering an alternative to open-heart surgery.

Dr. Messenger, a leader in interventional cardiology and structural heart innovation, heads the program at CU Anschutz. He serves as clinical director of the Heart & Vascular Center, director of the Cardiac Catheterization Laboratories, and director of the Cardiovascular ICU at UCHealth University of Colorado Hospital.

Chairholder: John Messenger, MD

Learn more about Dr. Messenger here

How the funds are being used:

---

This gift will support the chair holder through salary funding, student support, research expensed, conference participation, curriculum development, and other related activities.

Cardiology Imaging Endowed Chair

---

The Cardiology Imaging Programmatic Fund was established in 2020 with a $5M gift from a grateful patient who received exceptional care at CU Anschutz. The donor has provided an additional $25M to further support the Advanced Cardiac Imaging and Image Guidance program’s clinical and research initiatives.

Chairholder: Robert Quaife, MD

---

Dr. Robert Quaife, a Professor in the Division of Cardiology at the Anschutz Medical Campus, is dedicated to delivering high-quality cardiology care and consulting on complex critical care cases. As an advanced cardiac imaging specialist/ consultant, he plays a vital role in solving challenging clinical problems through procedural preplanning, 3D modeling and advanced imaging techniques that guide complex cardiovascular patient specific procedures.

Learn more about Dr. Quaife

How funds are being used:

---

Funds are being used to advance techniques and treatments in the cardiology field.

Celeste and Jack Grynberg Endowed Chair in Adult Diabetes Fund

---

Jack Grynberg and Dr. Draznin shared a close friendship that deepened when Jack became a devoted patient after his type 2 diabetes diagnosis. Though Jack has since passed, his legacy lives on through this endowed chair supporting clinical research. His wife, Celeste Grynberg, continues to honor that legacy by championing Dr. Draznin’s work and advancing diabetes research and education at CU Anschutz.

Chairholder: Boris Draznin, MD, PhD

---

Dr. Draznin’s research focuses on improving blood glucose control to enhance the lives of adults with diabetes. He and his team are leading a multi-center trial to evaluate how continuous glucose monitoring can help hospitalized patients maintain target glucose levels more effectively.

How the funds are being used:

---

The endowed chair has enabled the pursuit of cutting-edge technology that enhances life for people with diabetes. This support has been essential in designing and conducting the multi-center trial, advancing educational initiatives, and publishing several books in the field.

Frederic C. Hamilton Endowed Chair in Endocrinology

---

Frederic C. Hamilton was a visionary leader in the oil and gas industry, a dedicated philanthropist, and a champion of education and medical research. As the founder of Hamilton Oil Corporation, he played a pioneering role in global oil exploration, while his commitment to philanthropy left a lasting impact on institutions like the Denver Art Museum and the University of Colorado School of Medicine. His generous support established the Frederic C. Hamilton Endowed Chair in Endocrinology at the CU Department of Medicine, advancing groundbreaking research and innovation in the field. Hamilton’s legacy continues to fuel progress in medical discovery, ensuring a brighter future for endocrinology and patient care. 

Chairholder: Whitney Goldner, MD

---

Dr. Goldner is Professor and Head of the Division of Endocrinology, Metabolism, and Diabetes. She received her BA at Augustana College, and her MD from the University of Nebraska and completed her Internal Medicine training at the University of Utah and Endocrinology Fellowship at the University of Iowa. She founded the Thyroid and Endocrine Tumor Program at the University of Nebraska Medical Center and has been a member of both the NCCN and American Thyroid Association’s Thyroid Cancer Guidelines committees. Her clinical and research focus are on prevention and treatment of thyroid and endocrine tumors and optimization of thyroid cancer survivorship. Her research explores links between environmental exposures and thyroid neoplasms, with a goal of identifying novel risk factors as well as identifying rural-urban disparities in access to care, especially relevant in Colorado’s many rural communities. Her mission is individualize and optimize care for all persons with thyroid cancer.

How the funds are being used:

---

The Frederic C. Hamilton endowed chair supports innovative research in the field of thyroid diseases and thyroid cancer and helps advance clinical and translational research that has a significant impact on individualization of patient care.  I'm deeply grateful to be named to this chair, which will help advance our understanding of prevention, treatment, and outcomes for thyroid and endocrine tumors. Thank you to the Fredric C. Hamilton family for their generous support.

Previous Chairholder: Bryan Haugen, MD

Mary Rossick Kern and Jerome Kern Endowed Chair in Thyroid Tumor Research

---

Thanks to the vision and generosity of the Kern family, this chair was established to advance the exceptional research and clinical care that define the CU Division of Endocrinology. Their support fuels innovative research in thyroid cancer, expanding its impact well beyond traditional academic medicine.

Chairholder: Bryan Haugen, MD

---

I am a clinician-scientist focused on the care of patients with thyroid nodules and cancer. My research aims to better understand thyroid cancer progression and identify new therapeutic targets through the use of cell lines, innovative mouse models, and clinical trials.

Lucas Family Endowed Chair in Diabetes and Endocrinology

---

The Lucas Family Endowed Chair in Diabetes and Endocrinology was established with a $2 million gift from Steve and Shelley Lucas, longtime supporters of diabetes research and treatment. Nathaniel "Steve" Lucas is a CEO with 27 years of leadership experience in enterprise software, having held roles at Marketo, iCIMS, Adobe, SAP, Salesforce, and BusinessObjects. As CEO of Marketo and iCIMS, he led growth and successful acquisitions, including the $4.75 billion acquisition of Marketo by Adobe. Steve is also an advocate for Type 1 diabetes awareness, serving on the boards of the American Diabetes Association and the Children’s Diabetes Foundation. He holds a business degree from the University of Colorado and is a published author committed to giving back to the community. 

The Lucas’s generosity was inspired by the many years of compassionate patient care Dr. McDermott provided for Steve, a Type 1 diabetic. Steve also considers Dr. McDermott a personal mentor.

Chairholder: Michael McDermott, MD

---

Dr. Michael McDermott is a Professor of Medicine and Clinical Pharmacy in the Division of Endocrinology, Metabolism, and Diabetes at Anschutz Medical Campus. His mission is to provide world-class, person-centered care while working to eliminate healthcare disparities. Dr. McDermott is dedicated to finding a cure for all types of diabetes and improving treatment and quality of life for patients with diabetes.

How the funds are being used:

---

The endowment funds will support initiatives aimed at improving the lives of individuals with diabetes and other endocrine conditions at the University of Colorado Hospital. These funds will ensure patients receive the highest level of evidence-based, individualized care. Additionally, the endowment will enhance efforts to educate Endocrinology fellows, Internal Medicine and Family Medicine residents, medical students, and primary care faculty on the latest advancements in Diabetes and Endocrinology.

Kern Foundation Joel S. Levine, MD Endowed Chair

---

A group of dedicated benefactors—including the Kern Foundation, Rose Community Foundation, Patricia Crown, Lillian Irvin, and the CU Department of Medicine—came together to establish this chair, advancing research in inflammatory bowel disease at the University of Colorado.

Chairholder: Sean P. Colgan, PhD

---

Dr. Sean Colgan is a CU Distinguished Professor and the Joel Levine-Fred Kern, Jr. Professor of Medicine. Recruited from Harvard Medical School in 2006, he founded and directs CU’s Mucosal Inflammation Program, focused on discovering new mechanisms of inflammation in the gut. A recipient of an NIH R37 MERIT award, he leads a multi-R01-funded lab exploring innate immune responses in the GI tract. Dr. Colgan has published over 270 papers, held numerous leadership roles—including six years as Vice Chair of Medicine—and mentored more than 50 trainees worldwide, many of whom remain in academic medicine.

How the funds are being used:

---

Thanks to the generosity of the Kern Foundation, Rose Community Foundation, Patricia Crown, Lillian Irvin, and the Department of Medicine, this funding supports salary supplements for NIH grants and essential lab reagents—fueling critical research in inflammatory bowel disease.

The Waterman Family Endowed Chair

---

The Waterman Family Endowed Chair, generously supported by Sandy and Peter Keller, honors excellence in scientific research and innovation. This Chair serves as a lasting investment in advancing biomedical discovery, with a current focus on liver immunology and the role of lymphatic biology in chronic liver disease. By supporting high-impact investigators and fostering collaboration across disciplines, the Waterman Chair exemplifies the power of philanthropy to drive meaningful progress in human health.

Chairholder: Jennifer Christie, MD

---

Dr. Jennifer Christie is the Division Head of Gastroenterology and Hepatology at the CU Department of Medicine and the Immediate Past-President of the American Society for Gastrointestinal Endoscopy. She joined CU in September 2023 after serving in leadership at Emory University. A physician-scientist with over 100 publications, Dr. Christie’s work centers on GI motility disorders and health disparities. She’s been recognized for her mentorship, clinical excellence, and contributions to the field with honors including GI Mentor of the Year and Emory’s Outstanding Faculty Award.

Sissel Family Endowed Distinguished Clinician Chair

---

The Sissel Family Endowed Distinguished Clinician Chair at the University of Colorado Anschutz Medical Campus honors exceptional clinical contributions, particularly in internal medicine. Established through the generosity of the Sissel family, this prestigious position was first held by Dr. Ronald Colson, recognizing his outstanding work in the field. The chair is part of a broader initiative at CU Anschutz to support and celebrate faculty excellence, with other notable endowed chairs, including the Sissel & Findlow Family Endowed Chair in Stem Cell Research at the Barbara Davis Center for Diabetes.

Chairholder: Ronald S. Colson, MD, FACP

---

Dr. Colson has been a leading clinician throughout his career. Known for building thorough relationships based on trust and open communication with his patients, time was a rate-limiting factor in Dr. Colson’s ability to both see more patients and effectively train the next generation of compassionate care providers. Dr. Colson’s training programs emphasize the scientific and technical skills necessary for clinical excellence and the development of if interpersonal skills critical for building trust.

Learn more about Dr. Colson here

How the funds are being used:

---

Support from the generously endowed chair provides for recruitment and mentorship of early career faculty members in the Division of General Internal Medicine (GIM). It also has provided support for onboarding and mentoring of new Advanced Practice Providers (APPs) to GIM. These individuals focused on communication and clinical skills as they began their career in primary care internal medicine. 

Gordon Meiklejohn Endowed Chair for Internal Medicine

---

In 1951, Dr. Gordon Meiklejohn became chair of the Department of Medicine at the University of Colorado School of Medicine, a position he was to hold for 25 years. When he stepped down in 1976, Dr. Meiklejohn was one of the longest tenured department chairs in the country!​ Dr. Meiklejohn’s enormously productive research career focused on atypicall pneumonias and viral respiratory diseases, particularly influenza.​ Dr. Meiklejohn participated actively and enthusiastically in the World Health Organization’s Smallpox Eradication Program and made many field visits in support of that program in Zaire, Kenya, Uganda, Tanzania, Nigeria, Indonesia, and India. The Indians referred to him simply as ‘‘The Professor,’’ a name that truly fit.​ He was often described as quiet, thoughtful, wise, and soft-spoken, and he was all of those. Two characteristics stood out, however: unquestioned integrity and gentle humility. ​

Chairholder: Mark Earnest, MD, PhD

---

Mark Earnest, MD, is a professor of medicine and division head of General Internal Medicine in the Department of Medicine at the University of Colorado Anschutz Medical Campus, School of Medicine. He received his MD from Vanderbilt University School of Medicine and his PhD from the University of Colorado Denver. His research and academic interests include medical humanities, medical education and health policy.

How the funds are being used: 

---

Since its inception, the Gordon Meiklejohn Endowed Chair has been held by the Division Head of General Internal Medicine. The endowment has supported academic and research excellence in the GIM Division through an annual internal small grants program and a visiting professorship. In addition to these programs, the endowment has helped to support a variety of investigators who have needed one-time funds to sustain or build their research programs as well as provide start-up funding for strategic academic initiatives. Many of the small grants supported by the endowment have led to peer reviewed papers, created the pilot data needed to compete for larger extra-mural grants or enabled the start-up of novel programs or initiatives that have gone on obtain sustainable funding. The Meiklejohn endowment has been a critical driver of the Division’s success in becoming one of the top divisions nationally.

Brown/Moore Endowed Chair for Excellence in Patient Experience

---

This substantial contribution to the School of Medicine has been made possible thanks to the generosity of the Browns, the Bensons, the Sissels, and other benefactors.

Chairholder: Annie Moore, MD, MBA 

---

"A patient's experience in healthcare is individual and evolving. Combining patient diversity and the increasing complexity of healthcare, the patient experience is highly vulnerable. In this ever-changing landscape, I am to build coalition of those committed to the enhancement of the patient experience informed by patient listening," said Dr. Moore.

How the are funds being used:

---

The gift supports Dr. Moore’s work to improve the patient experience by focusing on both patient and clinician perspectives. It enables innovations that enhance care and define what an optimal, patient-centered experience looks like. The Chair's mission is to elevate patient experience as a healthcare priority through research, education, and national leadership. By promoting collaboration and listening to patient voices, the goal is to set new standards in care and exceed expectations across an increasingly complex healthcare system.

Goodstein Chair in Geriatrics, held by: Cari Levy

---

Dr. Cari Levy is Division Head of Geriatric Medicine at the CU School of Medicine and a Professor of Medicine with board certifications in Geriatrics and Hospice & Palliative Medicine. She completed her MD and PhD in health services research at CU, residency at Vanderbilt, and now leads research on innovative long-term care models as a core investigator at the Denver–Seattle Center for Veteran Centered and Value Driven Research. Her clinical work spans geriatrics and palliative care at both the Rocky Mountain Regional VA and University of Colorado Hospital.

How the funds are being used:

---

In 1985, the Goodstein Foundation established the Goodstein Endowed Professorship in Geriatric Research to support salary and benefits for the Division Head of Geriatric Medicine. This groundbreaking gift helped advance clinical research and patient care, and is believed to be the first of its kind—sparking a “domino effect” that has led to the creation of numerous named chairs and professorships across the institution.

Peter W. Shaughnessy Endowed Chair in Health Care Policy and Research

---

This Chair was created with gifts from Peter Shaughnessy and the CU Department of Medicine. The resources made available through this chair support research activities in health care policy, as well as a distinguished lecture series enabling faculty to share knowledge and support the work of colleagues.

Chairholder: Mark Gritz, PhD

---

Dr. R. Mark Gritz honors Dr. Peter Shaughnessy’s legacy by advancing health services, evidence-based policy, and long-term care quality. Supported by the Shaughnessy Endowed Chair, Dr. Gritz researches the health and well-being of underserved populations, focusing on children and young adults entering and exiting foster care. His team is also working with Colorado Medicaid to design and evaluate a value-based payment model aimed at improving the health of all Coloradans.

How funds are being used:

---

In addition to Dr. Gritz’s pioneering research, the Shaughnessy Endowed Chair has supported the professional development of junior faculty in the Division of Health Policy and Research. The funding enabled participation in key professional meetings and collaboration on projects such as nursing home quality measurement. Over the past two years, these funds contributed to the national expansion of the home health value-based purchasing demonstration, now a permanent CMS program, and helped disseminate lessons learned from nursing home infection control during the COVID-19 pandemic.

Nancy Carroll Allen Endowed Chair in Hematology Research

---

Dr. Robert Allen, who joined the University of Colorado in 1977 as the chief of the Division of Hematology, led the division for nearly 40 years. His groundbreaking discoveries have become standard practice in textbooks and clinical guides. Dr. Allen and his wife, Nancy Carol Allen, worked together at CU, making significant contributions to hematology research. The Allen family has generously funded four endowed chairs and contributed to two others, leaving an unmatched legacy in advancing care, research, and education in the field of hematology.

Chairholder: Craig T. Jordan, PhD

---

Dr. Jordan earned his bachelor's from UC Berkeley and a PhD at Princeton, focusing on hematopoietic stem cells. After post-doctoral research at MIT, he joined academia, holding positions at the University of Kentucky and University of Rochester before moving to the University of Colorado in 2013. With over 180 publications and significant NIH/NCI grants, Dr. Jordan is a prominent cancer researcher and has served on editorial boards for top journals. His honors include the Helen Hay Whitney Fellowship and the Stohlman Scholar Award.

How the funds are being used:

---

This chair supports physician-scientists in the School of Medicine focused on developing the most advanced, personalize care for people living with blood diseases.

The David, Sam, and Gabrielle Seligman Endowed Chair in Hematology

---

Named in honor of his children, this chair was funded by Dr. Paul Seligman and Dr. Robert and Nancy Allen to provide ongoing support for research in the CU Division of Hematology. This support ensures the division has the resources to attract and retain world-renowned physician-scientists for generations.

Chairholder: Brandon McMahon, MD

---

Dr. Brandon McMahon joined the University of Colorado in 2016, focusing clinically on thrombosis and myeloproliferative neoplasms (MPN). His research explores clotting and bleeding complications in cancer, evidence gaps in hematology, and new therapies for MPN. Previously at Northwestern University, he held leadership roles in the fellowship program and received multiple teaching awards. He earned his MD from SUNY-Upstate, completed his hematology fellowship at the University of Rochester, and is a graduate of the ASH Clinical Research Training Institute.

How the funds are being used:

---

This support ensures the division has the resources to attract and retain world-renowned physician-scientists for generations.

Cleo Meador and George R. Scott Endowed Chair in Hematology

---

Dr. Robert Allen was recruited to the University of Colorado in 1977 as chief of the Division of Hematology, where he served for nearly 40 years. His leadership and groundbreaking discoveries are now integral to medical practice, influencing textbooks and clinical guidelines. Alongside him, his wife, Nancy Carol Allen, made pivotal contributions in his lab. Together, they advanced the field of hematology. The Allen family has funded four endowed chairs at the CU School of Medicine and contributed to two others, a unique legacy that has shaped the division's success and ensured a lasting impact on research and education.

Chairholder: Eric Pietras, PhD

---

Eric Pietras, PhD, earned his BA in Biochemistry from Knox College and his PhD from UCLA. He completed postdoctoral work at UCSF before joining the University of Colorado’s Division of Hematology. Eric holds the Cleo Meador and George Ryland Scott Endowed Chair of Medicine in Hematology. He is currently the Associate Division Chief for Basic Research in the Division of Hematology and is responsible for leading the Division’s laboratory research efforts. He has over 75 publications and has received numerous awards including the Leukemia and Lymphoma Society Scholar Award, the Boettcher Foundation Webb-Waring Award, and funding from NIH and other sponsors.

How the funds are being used:

---

The Cleo Meador and George Ryland Scott Endowed Chair of Medicine in Hematology was established through generous gifts from Dr. Robert and Nancy Allen, along with the CU Department of Medicine. This chair supports innovative research in the Division of Hematology, helping transform care options for patients with blood disorders and diseases.

Robert H. Allen M.D., Endowed Chair in Hematology Research

---

Bob and Nancy moved to Colorado, where he became Director of the Division of Hematology at the University of Colorado, a role he held for 40 years. A leader in Vitamin B-12 and folate research, Bob published over 200 papers and earned 16 U.S. patents for diagnostic tests and treatments still considered the gold standard today. His key discoveries—such as B-12 analogs that caused misdiagnoses and flaws in early prenatal vitamins—transformed care for vitamin deficiencies. The first recipient of the NIH MERIT Award, he was also a devoted mentor whose trainees now practice worldwide. 

Chairholder: Daniel Pollyea, MD, MS

---

Dr. Pollyea earned his MD from the University of Chicago, completed his residency there, and served as Chief Medical Resident at Cook County Hospital. He trained in Hematology and Oncology at Stanford, where he also earned a Master’s in Epidemiology. Now Clinical Director of Leukemia Services and interim Division Chief of Hematology at the University of Colorado, he leads early-phase clinical trials and has received funding from the NIH and major hematology foundations. He has over 160 peer-reviewed publications and is a frequent speaker at national and international conferences. He is the Acute Myeloid Leukemia Guidelines Committee Chair for the National Comprehensive Cancer Network.

How the funds are being used:

---

Established by Robert H. Allen, MD, and Nancy C. Allen, this chair advances hematology at CU Anschutz, transforming the care available to patients for generations. These resources enhance laboratory and clinical research initiatives in the Division of Hematology.

Cleo Scott and Mitchell Vincent Allen Endowed Chair of Medicine in Hematology Research

---

Dr. Robert and Nancy Allen established this endowed chair to support vital research in hematologic diseases. Dr. Robert Allen, recruited to CU in 1977, led the Division of Hematology for nearly 40 years, laying the foundation for what is now a robust team of over 100 faculty and staff. His discoveries remain core to modern hematology education and clinical care. Nancy Allen, his partner in life and in science, played a key role in the lab's breakthroughs. Together, the Allens have fully funded four endowed chairs and contributed to two more—an unparalleled legacy of impact on research, education, and care at CU.

Chairholder: Sally Stabler, MD

---

Dr. Sally Stabler holds the Cleo Scott and Mitchell Vincent Allen Endowed Chair in Hematology Research, an honor she received in 2004 in recognition of her decades-long contributions to the field. With a career at the University of Colorado spanning over 40 years, Dr. Stabler is internationally recognized for her work on folate and vitamin B12 metabolism, serving as co-inventor on nine patents related to diagnosis and treatment of these deficiencies. She has published more than 200 peer-reviewed articles and continues to shape the next generation of clinicians and researchers through her mentorship and teaching across the medical school and fellowship programs.

How the funds are being used:

---

The Cleo Scott and Mitchell Vincent Allen Endowed Chair in Hematology Research helps attract and retain top talent in the Division of Hematology by providing critical support and resources that empower faculty to drive innovation in patient care, research, and education. This fund has been instrumental in enabling groundbreaking work in hematologic disorders and continues to help transform the division through sustained excellence in scholarship and mentorship.

Tim Gill Endowed Chair for AIDS Research

---

Tim Gill is a Colorado native, entrepreneur, and activist for positive social change who actively supports equal rights and opportunity for every citizen. He and his foundation work to counter discrimination based on sexual orientation and gender expression. His foundation has been a major factor in advancing equality and human rights for the LGBTQ community across the nation. In 1993 his generous donation established the Tim Gill Endowment and Distinguished Lectureship. He was a recipient of the University of Colorado Distinguished Service Award in 1998. The Professorship was established to support HIV research at the University of Colorado and to promote HIV education at the University and within the Colorado community. Each year a Tim Gill Distinguished Lecturer is selected based on expertise in HIV research and care, for their skill in teaching and for their humanism that informs and enhances their communities and the world.

Chairholder: Eric Poeschla, MD

---

Eric M. Poeschla, M.D., is Professor of Medicine (Infectious Diseases) in the Department of Medicine at the University of Colorado Anschutz Medical Campus. A molecular virologist, innate immunologist, and practicing infectious disease specialist, Dr. Poeschla focuses on HIV-1 and antiviral innate immunity. He received his M.D. from Yale and completed his internal medicine residency at UCSF during the height of the HIV/AIDS epidemic, a formative experience that led him to pursue a research career in basic virology.

Following tropical medicine training in Papua New Guinea, he completed a fellowship in infectious diseases and HIV molecular virology at UC San Diego. Before joining CU Anschutz as Division Head in 2014, he spent 15 years on the faculty at the Mayo Clinic. Over his career, he has been continuously federally funded for 27 years through grants from NIAID, NIDA, and the VA.

Dr. Poeschla’s laboratory investigates how cellular proteins regulate HIV-1 and other viral replication cycles, as well as innate immune defenses that prevent cross-species transmission. Early contributions included defining the life cycle of the feline immunodeficiency virus (FIV), developing the first FIV-based lentiviral vectors, and foundational advances in understanding of the HIV-1 cofactor LEDGF/p75. Supported by the Gill Foundation and NIH, his team has also explored innate immune factors shared by HIV-1 and other RNA viruses, characterized HIV-1 inhibitors like lenacapavir (GS-6207) and ALLINIs, and created a novel transgenic mouse model to study viral nucleic acid sensing, recognized by an NIH Avant Garde Award for HIV Research. Recently, his lab identified a natural HIV/SIV restriction in large bat species, a key finding in understanding zoonotic threats.

During his leadership, Dr. Poeschla significantly expanded the Infectious Diseases division and guided it through the COVID-19 pandemic. In 2024, he stepped down as Division Head to concentrate on advancing his research program.

How the funds are being used:

---

Established to address the urgent need for AIDS research, this chair supports the advancement of HIV research at the University of Colorado and promotes HIV education both at the university and within the Colorado community. With this generous gift, the Division of Infectious Diseases can attract and retain top physician-researchers to drive innovation and progress in the field of HIV.

Past Chairholders: Dr. Thomas Campbell, Dr. Edward Janoff, Dr. Robert T. Schooley

Robert F. and Patricia Young Connor Endowed Chair in Young Women's Breast Cancer Research Fund

---

The Connors have deep ties to the University of Colorado. Patricia earned her physician's assistant certificate here in 1982 and served as an assistant professor from 1987 to 1992. Their philanthropic connection began with a $20 gift to the Child Health Associate Program in 1983. By establishing this chair in honor of their parents, the Connors are creating a lasting legacy that will positively impact the university for years to come.

Chairholder: Virginia Borges, MD

---

Virginia Borges, MD, is a Professor of Medicine at the University of Colorado and holds the Robert C. and Patricia Young-Connor Endowed Chair in Young Women's Breast Cancer. She is the Deputy Head of the Division of Medical Oncology, Director of the Breast Cancer Research Program, and Director of the Young Women's Breast Cancer Translational Program. Dr. Borges' research focuses on young women's breast cancer, postpartum breast cancer, and the impact of pregnancy on breast cancer. She is dedicated to developing novel treatments that address the unique needs of young women with breast cancer.

How the funds are being used:

---

This endowed chair to support research in young women’s breast cancer, with the goal of improving outcomes for patients and giving hope to their families.

Margaret and Hugh Stapp Endowed Chair for Cancer Research

---

The Margaret and Hugh Stapp Endowed Chair for Cancer Research at CU Anschutz honors the Stapp family's legacy in advancing medical science. Held by Dr. Hatim Sabaawy, MD, PhD, MS, Professor of Medicine and Medical Oncology, this chair supports innovative cancer research in detection, treatment, and prevention. Dr. Sabaawy’s leadership bridges lab discoveries with clinical applications, enhancing patient outcomes through personalized medicine. The chair reflects the Stapp family's commitment to cancer research and CU’s dedication to oncology innovation.

Chairholder: Hatim Sabaawy, MD, PhD

---

Hatim Sabaawy, MD, PhD, Director of Personalized Medicine in the Division of Medical Oncology at CU School of Medicine, leads translational research across CU Cancer Center, Children’s Hospital Colorado, and UC Health. He aims to transform healthcare through personalized medicine, tailoring treatments to an individual’s genetic profile—an approach seen as the future of cancer treatment.

How the funds are being used: 

---

The fund is used in three main applications to: 1) Develop approaches for functional precision medicine and translation of research findings into the clinic for personalized therapy; 2) Advance single cell spatial mapping of the tumor microenvironment, by supporting these studies throughout the institute with spatial mapping applications in various cancers including lung cancer, pancreatic cancer, colorectal cancer, and brain cancers; and 3) Translate targeted epigenetic therapy for modulating the tumor microenvironment into novel approaches for combination therapy for these cancers.

Previous Chair Holder: Dr. S. Gail Exkhardt

Kerry and Megan Hicks Endowed Chair in Pulmonary Hypertension

---

Kerry and Megan Hicks have established the Kerry and Megan Hicks Endowed Chair in Pulmonary Hypertension to advance care, research, and training in this complex disease. Inspired by the exceptional care Kerry received from Dr. David Badesch — now the inaugural chair holder — the Hicks’ gift supports continued innovation at the University of Colorado in pulmonary vascular medicine. Their generosity also established the Hicks Endowed Lectureship, ensuring ongoing collaboration and discovery in pulmonary hypertension for years to come.

Chairholder: David Badesch, MD

---

Dr. Badesch is a Professor of Medicine, Director of the Pulmonary Hypertension Program, and holds the Kerry and Megan Hicks Endowed Chair in Pulmonary Hypertension at the University of Colorado. He has 184 publications and over 43,600 citations, serving on national and international trial committees in pulmonary hypertension. He led the development of the ACCP/CHEST Medical Therapy Guidelines and has received multiple prestigious awards, including the Outstanding Physician Award from the Pulmonary Hypertension Association. Dr. Badesch has been listed among the Best Doctors in America since 2001 and focusses on improving global pulmonary hypertension care.

How the funds are being used: 

---

The Kerry and Megan Hicks Endowed Chair in Pulmonary Hypertension: These funds are being used to support clinical research in the area of pulmonary hypertension, largely focused on the conduct of clinical trials and registries targeting the development of advanced therapies.

The Kerry and Megan Hicks Endowed Lectureship in Pulmonary Hypertension: These funds are being used to bring in outstanding lecturers from around the US and the world, to share their expertise in the area of pulmonary vascular disease and foster collaboration with investigators at the University of Colorado. We are exceedingly grateful for the generous support provided by Kerry and Megan Hicks for our research. It enables us to maintain the staffing and infrastructure critical to advancing our mission.

James C. Campbell Endowed Chair for Pulmonary Medicine

---

The James C. Campbell Endowed Chair for Pulmonary Medicine honors Jim Campbell, founder of LIFECARE, a pioneering company in home respiratory care. Jim grew LIFECARE into a successful business, providing ventilators to those in need, and was recognized as Exporter of the Year in 1994. A passionate philanthropist, Jim served on the boards of Wells Fargo Bank and the University of Colorado Foundation. This chair supports advancements in pulmonary medicine, carrying forward Jim’s legacy of innovation, community service, and generosity to the University of Colorado and beyond.

Chairholder: Fernando Holguin, MD

---

Dr. Fernando Holguin is a Pulmonologist and Professor of Medicine and Pediatrics at the University of Colorado Anschutz Medical Campus. With over 25 years of experience, he specializes in asthma, particularly severe and difficult-to-treat cases. Dr. Holguin is the Director of the UCARE Program, focusing on how obesity and metabolism affect asthma. He is an internationally recognized researcher with more than 170 publications and has contributed to clinical trials in asthma and COPD. Additionally, Dr. Holguin co-chairs the American Thoracic Society and European Respiratory Society Task Force on severe asthma. Outside of work, he enjoys skiing, biking, reading, and family time.

How the funds are being used:

---

James C. Campbell was able to realize his dream of giving back after receiving his undergraduate degree from CU Boulder. By establishing this chair in the Division of Pulmonary Sciences and Critical Care, he is creating a legacy of transforming lives and supporting the activities of early-career researchers.

Marsico Chair for Excellence in the Division of Pulmonary Sciences and Critical Care Medicine

---

Thomas F. Marsico is CEO of Marsico Capital Management, a firm he founded in 1997. He serves on advisory boards for the University of North Carolina, University of Denver, Denver Art Museum, and the Cystic Fibrosis Foundation. He also advises investment committees for the Rose Community Foundation and Daniels Fund. Cyndy R. Marsico is president of the CTM Foundation, which she and Thomas founded in 1997. She is active with Girls, Inc. of Metro Denver, the Junior League of Denver, and the Heart Association. The Marsico Endowed Chairs in Excellence Fund supports faculty members whose work has earned national or international recognition, such as the Nobel Prize or MacArthur Fellowship, to attract and retain outstanding scholars at the University.

Chairholder: Abigail Lara, MD

---

Abigail (Abbey) Lara is an Associate Professor of Medicine in the Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado School of Medicine, where she also holds the Marsico Endowed Chair for Excellence. She currently serves as the Assistant Dean for Faculty Relations leading efforts to foster professionalism, belonging, and humanism in academic medicine. A dedicated clinician, educator, and leader, Dr. Lara has held numerous leadership roles across GME, health equity, and faculty development, and is recognized nationally for her commitment to advancing professionalism and a culture of excellence in academic medicine. 

How the funds are being used: 

---

As the Marsico Endowed Chair for Excellence, Dr. Lara used the support of this role to strengthen and expand the institution’s commitment to professionalism in medicine. These efforts include the redesign and leadership of the Office for Faculty Relations within the Office for the Faculty Experience, where she leads initiatives that foster a culture of humanism, integrity, and accountability across the School of Medicine. The funds have supported the development and delivery of institution-wide professionalism education, including GME orientation sessions, faculty development seminars, and departmental workshops. Dr. Lara is also the chair of Personnel Affairs Committee, guiding interventions that uphold our shared values and support faculty and learners. This work is further integrated with broader institutional priorities through collaborations with belonging and learning environment efforts. The Marsico Chair has enabled her to dedicate time and resources to this critical mission, helping to shape a culture of respect and excellence at CU.

Thomas L. Petty Chair for Pulmonary Research

---

Dr. Thomas Petty was an internationally recognized respiratory physician, renowned for his contributions to the care of patients with chronic obstructive pulmonary disease (COPD). He advanced treatments like pulmonary rehabilitation and portable oxygen, improving quality of life for many. One of his early achievements at the University of Colorado in 1963 was adapting portable oxygen cylinders developed for the US space mission for COPD patients. He also first described Acute Respiratory Distress Syndrome (ARDS) and positive end-expiratory pressure ventilation which remains central for its treatment.

Chairholder: York Miller, MD

---

Dr. Miller has focused on understanding lung cancer susceptibility since his early training at CU. Elected to the American Society for Clinical Investigation in 1990, he has served as deputy editor for the American Journal of Respiratory and Critical Care Medicine and has had continuous research funding for over 40 years. His research explores ways to reduce lung cancer risk, with a particular focus on premalignant lesions. As head of the CU Colorado Pulmonary Premalignancy Program, he’s investigating natural reparative processes in the lungs and how to prevent premalignancy from evolving into cancer. In collaboration with Dr. Robert Keith and Dr. Mark Geraci, Miller led a clinical trial on iloprost, which became the first to successfully improve endobronchial premalignancy.

How the funds are being used: 

---

This fund was created to celebrate the life and work of Dr. Petty, and to further research in and impact on the field of pulmonary medicine. Dr. Petty’s many contributions to the field directly improved quality of life for thousands of patients. This fund supports the research career development of pulmonary fellows and junior faculty.

Roger S. Mitchell Endowed Chair in Lung and Critical Care Research

---

Under the leadership of Gordon Meiklejohn, MD, who served from 1951 to 1975, Roger Mitchell, MD, was recruited in 1955 as the first director of the Division of Pulmonary Sciences and Critical Care Medicine, a position he held until 1970. Dr. Mitchell was awarded the Trudeau Medal in 1980. The division graduated its first trainee in 1958 and initially focused on developing clinician-investigators in clinical and physiological sciences. By 1970, fewer than half of its graduates pursued academic careers. In the years following, a national shortage of academic pulmonologists in both clinical and scientific disciplines was recognized.

Chairholder: Marc Moss, MD

---

Dr. Moss is the Roger S. Mitchell Professor of Medicine and former Head of the Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado. His research, supported by over 22 years of NIH funding, focuses on Acute Respiratory Distress Syndrome (ARDS), neuromuscular dysfunction in critically ill patients, and wellness in healthcare professionals. He leads the Colorado center in the NHLBI/NIGMS APS network and the Colorado Resiliency Arts Lab (CORAL). Dr. Moss served as Program Director for the CCTSI’s Education, Training, and Career Development Core and was President of the American Thoracic Society from 2017-2018.

How the funds are being used: 

---

In honor of Dr. Roger Mitchell, who dedicated his career to providing high-quality patient care, this chair was established to support research and care in lung disease. This funding fuels research in lung disease that will someday change lives by leading to improved prevention and treatment options.

Mats Wahlstorm Endowed Chair in Nephrology

---

Following a 30-year career in leading one of the world's foremost kidney disease health care companies, the Wahlstrom family created this chair to fuel clinical research in the Division of Nephrology at CU. This chair helps CU attract and retain the best and brightest physicians from around the world. Mats and Agneta Wahlstrom provided a major gift to the Division of Renal Diseases and Hypertension with the establishment of the Wahlstrom Endowed Chair and Lectureship.​Proceeds from this Chair are used to support the clinical research of the Division, and the yearly Visiting Professorship honors a leader in the field of Nephrology and Dialysis.​

Chairholder: Michel Chonchol, MD

---

Michel B. Chonchol, MD, is a Professor of Medicine at the University of Colorado Anschutz Medical Campus. He completed an internship and a residency in Internal Medicine at the University of Texas Health Science Center at Houston, as well as a clinical and research fellowship in Nephrology at the University of Colorado Anschutz Medical Campus. Dr. Chonchol serves as the Head of the Division of Renal Diseases and Hypertension at the University of Colorado Anschutz Medical Campus. Has established himself as a national and international leader in clinical nephrology. He is significantly productive, with over 400 publications, and has been invited to lecture nationally and internationally. He is well-funded by the National Institute of Health and Industry. Dr Chonchol’s research interests are to explore traditional and non-traditional risk factors in patients with chronic kidney disease and polycystic kidney disease that could explain the high rate of death and cardiovascular events, as well as kidney disease progression observed in this patient population.

How the funds are being used: 

---

The Mats Wahlstrom Endowed Chair in Nephrology and Lectureship have significantly advanced clinical research and education in kidney disease at CU Anschutz. The lectureship brings top kidney experts to campus, sparking innovative research and improved care. Over the past decade, the division has doubled in size, with faculty leading cutting-edge translational research and training future leaders. It remains one of the top NIH-funded divisions in the Department of Medicine. This endowment fuels bold, promising research and strengthens our position as a national leader in nephrology, turning lab discoveries into better outcomes for patients.

Rocky Mountain Endowed Chair in Renal Research

---

The Rocky Mountain Endowed Chair supports kidney research at the University of Colorado Anschutz Medical Campus, focusing on young basic science investigators through career development awards. This endowment is crucial for advancing research in the Division of Nephrology, helping it strive toward becoming one of the nation's top kidney research centers. The funds support infrastructure, personnel, novel technologies, and pilot projects, enabling competitive, cutting-edge research aimed at improving clinical outcomes for kidney disease patients.

Chairholder: Stuart Linas, MD

---

Dr. Linas is the Rocky Mountain Professor of Renal Research at the University of Colorado School of Medicine and Chief of Nephrology at Denver Health Medical Center. He served as the Renal Fellowship Director from 1984 to 2016 and has led the Section of Hypertension since 1994. Dr. Linas has earned numerous teaching awards and held leadership roles with the American Board of Internal Medicine and the American Society of Nephrology. He completed his medical degree at Tufts University and his residency and nephrology training at the University of Colorado.

How the funds are being used:

---

University of Colorado Medicine, formerly University Physicians, Inc., provides critical resources to the CU Anschutz Medical Campus in support of research and education programs. This chair, funds in partnership with the Division of Renal Diseases and Hypertension, ensures that CU Faculty have the resources they need to make.

Temple Hoyne Buell and National Kidney Foundation Endowed Chair

---

Temple Hoyne Buell, a renowned architect and philanthropist in Denver, made a lasting impact on the city with his design of some of its most historic buildings. Awarded honorary doctorates from Columbia University and the University of Colorado, he was posthumously inducted into the Colorado Business Hall of Fame in 2013. The Temple Hoyne Buell Foundation, established in 1962, supported major capital projects and endowed positions at universities from 1985 to 1988. For 75 years, the National Kidney Foundation has been transforming kidney care through groundbreaking research, patient advocacy, and community support.

Chairholder: Joshua Thurman, MD

---

Joshua M. Thurman, MD, is the Temple Hoyne Buell Professor of Medicine in the Division of Nephrology and Hypertension at the University of Colorado. A faculty member since completing his fellowship in 2003, Dr. Thurman specializes in treating autoimmune kidney diseases and has led clinical trials exploring new therapies. His NIH-funded research focuses on the mechanisms of autoimmunity and kidney inflammation. His lab has developed innovative anti-inflammatory treatments and imaging tools, including MRI and PET probes, to better detect and monitor kidney disease.

How the funds are being used:

---

The Temple Hoyne Buell Foundation and the National Kidney Foundation established this chair to advance kidney disease research. Funding supports innovative pilot studies, including Dr. Thurman’s work on transcriptomic analysis of kidney biopsies and the development of novel imaging probes for non-invasive detection of inflammation. These tools help improve disease monitoring and guide more targeted treatments. With support from this endowed chair, Dr. Thurman is leading efforts to make earlier detection and better care a reality for patients with kidney disease.

Charles Boettcher II Endowed Chair in Atherosclerosis Research

---

The Charles Boettcher II Endowed Chair in Atherosclerosis Research honors the legacy of Charles Boettcher II, a dedicated Coloradan who spent much of his life in Denver. Born on September 21, 1901, Charles was a passionate philanthropist committed to improving society. He married Anna Lou Pigott in 1926 and spent his professional life as a broker in investments. His dedication to community and societal betterment continues through the Boettcher Foundation, which generously endowed this chair at CU Anschutz. This fund supports groundbreaking research in atherosclerosis, a key area of study in cardiovascular health.

Chairholder: Mary Weiser-Evans, PhD

---

Coronary artery atherosclerosis is a leading cause of death worldwide and a deeply personal focus for Dr. Mary C.M. Weiser-Evans, who lost multiple family members and her mentor to sudden heart attacks. While cholesterol-lowering therapies and stents are standard treatments, many patients remain at high risk due to inflammation and vascular cell changes.

Dr. Weiser-Evans is the Charles Boettcher II Professor of Medicine in the Division of Renal Medicine and Hypertension at CU Anschutz. With over 25 years of research, her work centers on vascular smooth muscle cell signaling and the role of a novel vascular stem cell (AdvSca1-SM) in cardiovascular disease.

How the funds are being used:

---

The Boettcher funds have been instrumental in facilitating our ability to secure larger NIH grants to support our work. These funds continue to support the salary of a junior faculty member as he works toward establishing his own independent research laboratory focused on cardiovascular disease.  Finally, these funds have supported the salaries of previous and current graduate students who made initial observations that systemic up regulation of PTEN is vascular protective, that AdvSca1-SM cells are instrumental in driving atherosclerosis, and translationally relevant studies using nanoparticle-based PTEN delivery as a novel therapeutic approach to limit atherosclerosis and restenosis lesion progression. 

Previous Chair Holder: Robert Eckel, MD, FAHA, FACC, FNLA

William P. Arend Endowed Chair in Rheumatology

---

This endowed chair was established by Dr. William (Bill) Arend and his family to support research in rheumatology and autoimmune diseases. Dr. Arend led the Division of Rheumatology at the University of Colorado from 1983 to 2000, guiding its rise to national prominence. A renowned scientist and mentor, he is best known for discovering the IL-1 receptor antagonist (IL-1Ra), which became the drug anakinra—a key therapy for autoimmune and inflammatory diseases.

Chairholder: Kevin Deane, MD

---

Dr. Kevin Deane, a rheumatologist, is honored to hold the Arend Endowed Chair, having begun his research career under the mentorship of Dr. Bill Arend. He has led the first rheumatoid arthritis prevention trial in the U.S. and, with support from the chair and the Autoimmune Disease Prevention Center launched in 2024, continues to advance research, education, mentorship, and clinical care—working toward a future where autoimmune disease prevention is part of everyday medicine.

How the funds are being used:

---

The William P. Arend Endowed Chair for Rheumatology Research has advanced key discoveries in rheumatoid arthritis (RA), particularly the role of the lung and gut as potential early sites of disease development—before arthritis even begins. These insights have opened new avenues for prevention and treatment. The chair also supports training for students and residents in Dr. Kevin Deane’s lab, fostering the next generation of rheumatology researchers and clinicians. Dr. Arend, a pioneering leader in the field, passed away in 2020.

Charley J. Smyth Chair in Rheumatology Research

---

This chair was established by the Arthritis Foundation and the Helen and Arthur E. Johnson Foundation to honor and celebrate Dr. Smyth’s distinguished career and lifelong contributions to rheumatology. As a pioneer in his field, it was important for Dr. Smyth to support innovative new thinkers for generations. 

Chairholder: Vernon M. Holers, MD

---

Dr. Michael Holers is a professor of Medicine in the Division of Rheumatology in the Department of Medicine at the University of Colorado School of Medicine. He serves as Director of Faculty Ventures at CU Innovations. He has helped the division advance its research and clinical care, focusing on the immune system’s role in autoimmune diseases. Dr. Holers is committed to improving patient outcomes and fostering an environment of innovation and excellence within the division, guiding his team to new frontiers in understanding and treating rheumatic diseases.

“It is vital that we receive this type of generous support so that we are able to accelerate projects that hold the promise of groundbreaking advancements. We are appreciative of the belief and trust placed in our work. Their contributions empower us to push the boundaries of scientific discovery and strive for innovations that can profoundly impact lives.

How the funds are being used:

---

One of Dr. Holers’ significant contributions is his preclinical program focused on the pathogenesis and prevention of rheumatoid arthritis (RA). His research delves into the complement system, which, when overactive, contributes to inflammation and tissue damage in RA> By developing preclinical models, Dr. Holers aims to identify early markers and potential therapeutic targets before clinical symptoms appear, paving the way for more effective prevention strategies.

Dr. Holers and his team have prioritize exploring uncharted territories with the potential for transformative discoveries. These innovative research projects often carry inherent uncertainties, but their success can lead to groundbreaking treatments and preventative measures that can drastically improve patient outcomes. In the case of Dr. Holers’ work on RA, such research aims to uncover new mechanisms of disease and identify novel targets for prevention, ultimately striving to stop RA before it manifests.

Previous Chair Holder: Dr. Susan A. Boackle (2008-2015) Dr. Vernon Holers (1993-2008)

Kathryne E. and David M. Scoville Chair, held by, Kristine A. Kuhn, MD, PhD

---

Dr. Kuhn is the Scoville Endowed Chair, Head of the Division of Rheumatology, and Professor of Medicine and Immunology & Microbiology at the University of Colorado Anschutz Medical Campus. She leads the Division with a clear vision: to be the leader in shaping rheumatologic care through discovery and innovation. Dr. Kuhn's research has uncovered critical roles for specific bacteria and their byproducts in the development of spondyloarthritis and rheumatoid arthritis. In addition to her scientific contributions, she has built a dynamic and multidisciplinary team, recruiting top-tier talent to investigate diverse pathways involved in the onset—and potential prevention—of rheumatic diseases. Under her leadership, the Division has seen substantial growth in clinical services and training of the next generation of rheumatologists.

How the funds are being used:

---

This endowed chair established by the Scoville family is to support advancing the mission of the Division of Rheumatology in the Department of Medicine. Currently funds are being used to recruit and retain talented faculty in the division.